Monoclonal antibody binding to the macrophage-specific receptor sialoadhesin alters the phagocytic properties of human and mouse macrophages

Cellular Immunology

Volumn 312, Issue , 2017, Pages 51-60

  De Schryver, Marjorie ^a   Cappoen, Davie ^a   Elewaut, Dirk ^b,c   Nauwynck, Hans J ^d   Maes, Louis ^a   Caljon, Guy ^a   Cos, Paul ^a   Delputte, Peter L ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

Immunotherapy; Inflammation; Macrophages; Phagocytosis; Sialoadhesin CD169 Siglec 1

Indexed keywords

FC RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 12A4; MONOCLONAL ANTIBODY SYSY94; POLYSTYRENE; SIALOADHESIN; SIALOADHESIN MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; PROTEIN BINDING;

ANIMAL CELL; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL STIMULATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; ESCHERICHIA COLI; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MOUSE; NONHUMAN; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; DRUG EFFECTS; IMMUNOLOGY; INFLAMMATION; METABOLISM; SPECIES DIFFERENCE;

ANIMALS; ANTIBODIES, MONOCLONAL; CELLS, CULTURED; HUMANS; INFLAMMATION; MACROPHAGES; MICE; MICE, INBRED BALB C; PHAGOCYTOSIS; PROTEIN BINDING; SIALIC ACID BINDING IG-LIKE LECTIN 1; SPECIES SPECIFICITY;

EID: 85007553614     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2016.11.009     Document Type: Article

References (57)

1. [1] C.A. Janeway, Jr., P. Travers, M. Walport, M.J. Shlomchik, Principles of innate and adaptive immunity, (2001).
2. [2] Aderem, A., Underhill, D.M., Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17 (1999), 593–623.
3. [3] Taylor, A.E., Finney-Hayward, T.K., Quint, J.K., Thomas, C.M., Tudhope, S.J., Wedzicha, J.A., Barnes, P.J., Donnelly, L.E., Defective macrophage phagocytosis of bacteria in COPD. Eur. Respir. J. 35 (2010), 1039–1047.
4. [4] Hodge, S., Hodge, G., Scicchitano, R., Reynolds, P.N., Holmes, M., Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol. Cell Biol. 81 (2003), 289–296.
5. [5] Fisman, D.N., Hemophagocytic syndromes and infection. Emerg. Infect. Dis. 6 (2000), 601–608.
6. [6] Kane, L.P., T cell Ig and mucin domain proteins and immunity. J. Immunol. 184 (2010), 2743–2749.
7. [7] Foks, A.C., Engelbertsen, D., Kuperwaser, F., Alberts-Grill, N., Gonen, A., Witztum, J.L., Lederer, J., Jarolim, P., DeKruyff, R.H., Freeman, G.J., Lichtman, A.H., Blockade of Tim-1 and Tim-4 enhances atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 36 (2016), 456–465.
8. [8] De Baere, M.I., Van Gorp, H., Nauwynck, H.J., Delputte, P.L., Antibody binding to porcine sialoadhesin reduces phagocytic capacity without affecting other macrophage effector functions. Cell. Immunol. 271 (2011), 462–473.
9. [9] O'Neill, A.S.G., van den Berg, T.K., Mullen, G.E.D., Sialoadhesin – a macrophage-restricted marker of immunoregulation and inflammation. Immunology 138 (2013), 198–207.
10. [10] Xiong, Y.S., Cheng, Y., Lin, Q.S., Wu, A.L., Yu, J., Li, C., Sun, Y., Zhong, R.Q., Wu, L.J., Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis. Rheumatology 53 (2014), 250–259.
11. [11] Bornstein, G.G., Antibody drug conjugates: preclinical considerations. AAPS J. 17 (2015), 525–534.
12. [12] Leonard, J.P., Goldenberg, D.M., Preclinical and clinical evaluation of epratuzumab (anti-CD22 IgG) in B-cell malignancies. Oncogene 26 (2007), 3704–3713.
13. [13] Pino, M., Erkizia, I., Benet, S., Erikson, E., Fernandez-Figueras, M.T., Guerrero, D., Dalmau, J., Ouchi, D., Rausell, A., Ciuffi, A., Keppler, O.T., Telenti, A., Krausslich, H.G., Martinez-Picado, J., Izquierdo-Useros, N., HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells. Retrovirology, 12, 2015, 37.
14. [14] Delputte, P.L., Van Breedam, W., Delrue, I., Oetke, C., Crocker, P.R., Nauwynck, H.J., Porcine arterivirus attachment to the macrophage-specific receptor sialoadhesin is dependent on the sialic acid-binding activity of the N-terminal immunoglobulin domain of sialoadhesin. J. Virol. 81 (2007), 9546–9550.
15. [15] Van Gorp, H., Van Breedam, W., Delputte, P.L., Nauwynck, H.J., The porcine reproductive and respiratory syndrome virus requires trafficking through CD163-positive early endosomes, but not late endosomes, for productive infection. Arch. Virol. 154 (2009), 1939–1943.
16. [16] Delputte, P.L., Van Gorp, H., Favoreel, H.W., Hoebeke, I., Delrue, I., Dewerchin, H., Verdonck, F., Verhasselt, B., Cox, E., Nauwynck, H.J., Porcine sialoadhesin (CD169/Siglec-1) is an endocytic receptor that allows targeted delivery of toxins and antigens to macrophages. PLoS ONE, 6, 2011, e16827.
17. [17] Delrue, I., Van Gorp, H., Van Doorsselaere, J., Delputte, P.L., Nauwynck, H.J., Susceptible cell lines for the production of porcine reproductive and respiratory syndrome virus by stable transfection of sialoadhesin and CD163. BMC Biotechnol., 10, 2010, 48.
18. [18] Izquierdo-Useros, N., Lorizate, M., Puertas, M.C., Rodriguez-Plata, M.T., Zangger, N., Erikson, E., Pino, M., Erkizia, I., Glass, B., Clotet, B., Keppler, O.T., Telenti, A., Krausslich, H.G., Martinez-Picado, J., Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides. PLoS Biol., 10, 2012, e1001448.
19. [19] Vanderheijden, N., Delputte, P.L., Favoreel, H.W., Vandekerckhove, J., Van Damme, J., van Woensel, P.A., Nauwynck, H.J., Involvement of sialoadhesin in entry of porcine reproductive and respiratory syndrome virus into porcine alveolar macrophages. J. Virol. 77 (2003), 8207–8215.
20. [20] Chen, W.C., Kawasaki, N., Nycholat, C.M., Han, S., Pilotte, J., Crocker, P.R., Paulson, J.C., Antigen delivery to macrophages using liposomal nanoparticles targeting sialoadhesin/CD169. PLoS ONE, 7, 2012, e39039.
21. [21] De Schryver, M., Van Gorp, H., Hoebeke, I., De Maeyer, B., Ooms, K., Pintelon, I., Maes, L., Cos, P., Nauwynck, H., Delputte, P., Development and characterization of new species cross-reactive anti-sialoadhesin monoclonal antibodies. Antibodies, 5, 2016, 7.
22. [22] Klaas, M., Crocker, P.R., Sialoadhesin in recognition of self and non-self. Semin. Immunopathol. 34 (2012), 353–364.
23. [23] Zheng, Q., Hou, J., Zhou, Y., Yang, Y., Xie, B., Cao, X., Siglec1 suppresses antiviral innate immune response by inducing TBK1 degradation via the ubiquitin ligase TRIM27. Cell Res. 25 (2015), 1121–1136.
24. [24] Pillai, S., Netravali, I.A., Cariappa, A., Mattoo, H., Siglecs and immune regulation. Annu. Rev. Immunol. 30 (2012), 357–392.
25. [25] Crocker, P.R., Gordon, S., Properties and distribution of a lectin-like hemagglutinin differentially expressed by murine stromal tissue macrophages. J. Exp. Med. 164 (1986), 1862–1875.
26. [26] Heikema, A.P., Bergman, M.P., Richards, H., Crocker, P.R., Gilbert, M., Samsom, J.N., van Wamel, W.J., Endtz, H.P., van Belkum, A., Characterization of the specific interaction between sialoadhesin and sialylated Campylobacter jejuni lipooligosaccharides. Infect. Immun. 78 (2010), 3237–3246.
27. [27] Jones, C., Virji, M., Crocker, P.R., Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake. Mol. Microbiol. 49 (2003), 1213–1225.
28. [28] Chang, Y.C., Olson, J., Louie, A., Crocker, P.R., Varki, A., Nizet, V., Role of macrophage sialoadhesin in host defense against the sialylated pathogen group B Streptococcus. J. Mol. Med. 92 (2014), 951–959.
29. [29] Ooms, K., Van Gorp, H., Botti, S., Van Gaever, T., Delputte, P.L., Nauwynck, H.J., Evaluation of viral peptide targeting to porcine sialoadhesin using a porcine reproductive and respiratory syndrome virus vaccination-challenge model. Virus Res. 177 (2013), 147–155.
30. [30] Veninga, H., Borg, E.G.F., Vreeman, K., Taylor, P.R., Kalay, H., van Kooyk, Y., Kraal, G., Martinez-Pomares, L., den Haan, J.M.M., Antigen targeting reveals splenic CD169+macrophages as promoters of germinal center B-cell responses. Eur. J. Immunol. 45 (2015), 747–757.
31. [31] Kawasaki, N., Vela, J.L., Nycholat, C.M., Rademacher, C., Khurana, A., van Rooijen, N., Crocker, P.R., Kronenberg, M., Paulson, J.C., Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), 7826–7831.
32. [32] Nycholat, C.M., Rademacher, C., Kawasaki, N., Paulson, J.C., In silico-aided design of a glycan ligand of sialoadhesin for in vivo targeting of macrophages. J. Am. Chem. Soc. 134 (2012), 15696–15699.
33. [33] Hansel, T.T., Kropshofer, H., Singer, T., Mitchell, J.A., George, A.J., The safety and side effects of monoclonal antibodies. Nat. Rev. Drug Discovery 9 (2010), 325–338.
34. [34] Wilson, D.S., Wu, J., Peluso, P., Nock, S., Improved method for pepsinolysis of mouse IgG(1) molecules to F(ab′)(2) fragments. J. Immunol. Methods 260 (2002), 29–36.
35. [35] Mogensen, T.H., Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol. Rev. 22 (2009), 240–273.
36. [36] Janeway, C.A. Jr., Medzhitov, R., Innate immune recognition. Annu. Rev. Immunol. 20 (2002), 197–216.
37. [37] Kong, E., Jabra-Rizk, M.A., The great escape: pathogen versus host. PLoS Pathog., 11, 2015, e1004661.
38. [38] May, R.C., Machesky, L.M., Phagocytosis and the actin cytoskeleton. J. Cell Sci. 114 (2001), 1061–1077.
39. [39] van der Kuyl, A.C., van den Burg, R., Zorgdrager, F., Groot, F., Berkhout, B., Cornelissen, M., Sialoadhesin (CD169) expression in CD14+ cells is upregulated early after HIV-1 infection and increases during disease progression. PLoS ONE, 2, 2007, e257.
40. [40] Hartnell, A., Steel, J., Turley, H., Jones, M., Jackson, D.G., Crocker, P.R., Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. Blood 97 (2001), 288–296.
41. [41] Muerkoster, S., Wachowski, O., Zerban, H., Schirrmacher, V., Umansky, V., Rocha, M., Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages. Clin. Cancer Res. 4 (1998), 3095–3106.
42. [42] Scott, A.M., Wolchok, J.D., Old, L.J., Antibody therapy of cancer. Nat. Rev. Cancer 12 (2012), 278–287.
43. [43] Dawson, M., Wirtz, D., Hanes, J., Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport. J. Biol. Chem. 278 (2003), 50393–50401.
44. [44] Crocker, P.R., Mammalian Carbohydrate Recognition Systems. 2012, Springer Science & Business Media.
45. [45] Haydon, D.A., The surface charge of cells and some other small particles as indicated by electrophoresis. II. The interpretation of the electrophoretic charge. Biochim. Biophys. Acta 50 (1961), 457–462.
46. [46] Zhang, Y., Yang, M., Portney, N.G., Cui, D., Budak, G., Ozbay, E., Ozkan, M., Ozkan, C.S., Zeta potential: a surface electrical characteristic to probe the interaction of nanoparticles with normal and cancer human breast epithelial cells. Biomed. Microdevices 10 (2008), 321–328.
47. [47] Bondar, O.V., Saifullina, D.V., Shakhmaeva II, Mavlyutova II, Abdullin, T.I., Monitoring of the zeta potential of human cells upon reduction in their viability and interaction with polymers. Acta Nat. 4 (2012), 78–81.
48. [48] Aderem, A., Phagocytosis and the inflammatory response. J. Infect. Dis. 187:Suppl. 2 (2003), S340–S345.
49. [49] Weiss, G., Schaible, U.E., Macrophage defense mechanisms against intracellular bacteria. Immunol. Rev. 264 (2015), 182–203.
50. [50] Stuart, L.M., Deng, J., Silver, J.M., Takahashi, K., Tseng, A.A., Hennessy, E.J., Ezekowitz, R.A., Moore, K.J., Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain. J. Cell Biol. 170 (2005), 477–485.
51. [51] Underhill, D.M., Goodridge, H.S., Information processing during phagocytosis. Nat. Rev. Immunol. 12 (2012), 492–502.
52. [52] Huizinga, R., Easton, A.S., Donachie, A.M., Guthrie, J., van Rijs, W., Heikema, A., Boon, L., Samsom, J.N., Jacobs, B.C., Willison, H.J., Goodyear, C.S., Sialylation of Campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice. PLoS ONE, 7, 2012, e34416.
53. [53] Heikema, A.P., Koning, R.I., Duarte dos Santos Rico, S., Rempel, H., Jacobs, B.C., Endtz, H.P., van Wamel, W.J., Samsom, J.N., Enhanced, sialoadhesin-dependent uptake of Guillain-Barre syndrome-associated Campylobacter jejuni strains by human macrophages. Infect. Immun. 81 (2013), 2095–2103.
54. [54] Kwiatkowska, K., Sobota, A., Signaling pathways in phagocytosis. BioEssays 21 (1999), 422–431.
55. 2-exposed rats. Respir. Res., 7, 2006, 4.
56. [56] Johnston, L.K., Rims, C.R., Gill, S.E., McGuire, J.K., Manicone, A.M., Pulmonary macrophage subpopulations in the induction and resolution of acute lung injury. Am. J. Respir. Cell Mol. Biol. 47 (2012), 417–426.
57. [57] Janka, G., Imashuku, S., Elinder, G., Schneider, M., Henter, J.I., Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol. Oncol. Clin. North Am. 12 (1998), 435–444.